Nanjing Leads tests investor appetite for Lag3
But BeOne canned its alcestobart deal in May.
Sino takes out the rest of Merck’s partner
LaNova, which licensed a PD-1 x VEGF to Merck, is acquired by another Chinese player.
AbbVie steps up for Glenmark's multispecific
The deal for ISB 2001 is worth $700m up front.
Concentra picks up a new Cargo
The Tang Capital Partners vehicle has already acquired IGM, Elevation and Kronos.
